You are here

  • Home
  • Archive
  • Volume 26, Issue 9
  • Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7)

Article info

Article menu
Download PDFPDF
Uterine Cancer
Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7)

Authors

  1. Address correspondence and reprint requests to: Philipp Harter, MD, Department of Gynecology & Gynecologic Oncology, Kliniken Essen Mitte, Evang. Huyssens-Stiftung/Knappschaft GmbH, Henricistr 92, 45136 Essen, Germany. E-mail: p.harter{at}kliniken-essen-mitte.de.

Citation

Harter P, Sehouli J, Reuss A, et al
Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7)
International Journal of Gynecologic Cancer 2016;26:1636-1641.

Publication history

  • Received March 21, 2016
  • Accepted July 3, 2016
  • First published November 1, 2016.
Online issue publication 
February 27, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.